Switch to:
GuruFocus has detected 6 Warning Signs with Teva Pharmaceutical Industries Ltd $TEVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Accounts Payable
{IF BankInsurance_zone 1}
$6,421 Mil (As of )Dec. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

Teva Pharmaceutical Industries Ltds quarterly accounts payable increased from Jun. 2016 ($3,855 Mil) to Sep. 2016 ($3,855 Mil) and increased from Sep. 2016 ($4,953 Mil) to Dec. 2016 ($6,421 Mil)

Teva Pharmaceutical Industries Ltds quarterly accounts payable increased from Dec. 2014 ($3,171 Mil) to Dec. 2015 ($3,171 Mil) and increased from Dec. 2015 ($4,309 Mil) to Dec. 2016 ($6,421 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


Teva Pharmaceutical Industries Ltd Annual Data

Accts Payable 1,3832,2442,3492,5253,5723,3763,3173,1714,3096,421
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 2,8943,1713,0362,9762,9644,3093,5283,8554,9536,421

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)